Form 8-K - Current report:
SEC Accession No. 0001193125-23-213897
Filing Date
2023-08-16
Accepted
2023-08-16 08:15:51
Documents
14
Period of Report
2023-08-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d489292d8k.htm   iXBRL 8-K 23234
2 EX-99.1 d489292dex991.htm EX-99.1 29701
6 GRAPHIC g489292g0816075412652.jpg GRAPHIC 2415
  Complete submission text file 0001193125-23-213897.txt   183263

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20230816.xsd EX-101.SCH 2874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20230816_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20230816_pre.xml EX-101.PRE 10828
8 EXTRACTED XBRL INSTANCE DOCUMENT d489292d8k_htm.xml XML 3203
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 231176533
SIC: 2836 Biological Products, (No Diagnostic Substances)